SCHEMBL750757

SCHEMBL750757

CC1(C)CN(Cc2ccc(OC(F)(F)F)c(Cl)c2)C(c2c(F)cccc2F)O1

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 18/20 0.50
HCRTR2 O43614 18/20 0.50
RIPK3 Q9Y572 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL750659 0.90 HCRTR1 (0.44) HCRTR1HCRTR2
SCHEMBL751743 0.80 HCRTR1 (0.56) HCRTR1HCRTR2
SCHEMBL2135121 0.70 HCRTR1 (0.50) HCRTR1HCRTR2
SCHEMBL752475 0.69 HCRTR1 (0.61) HCRTR1HCRTR2
SCHEMBL751030 0.69 HCRTR1 (0.52) HCRTR1HCRTR2
SCHEMBL752840 0.69 HCRTR1 (0.57) HCRTR1HCRTR2
SCHEMBL4535385 0.67 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL4542034 0.67 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL4542031 0.67 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL4535387 0.67 HCRTR1 (1.00) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430004-A2 NOVEL OXAZOLIDINONE DERIVATIVES AND THEIR USE AS OREXIN RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2012-03-21 EP claimed
WO-2010131192-A2 NOVEL OXAZOLIDINONE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2010-11-18 WO claimed